Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence

Gastroenterology
T S HalstensenP Brandtzaeg

Abstract

Extensively washed and ethanol-fixed colonic specimens from 10 patients with ulcerative colitis, 3 patients with Crohn's disease of the colon, and 8 histologically normal controls were examined by two-color immunohistochemistry with monoclonal antibody to a neoepitope in the terminal complement complex combined with antiserum to factor VIII-related antigen (von Willebrand's factor), C3c, C3d, or C5. An alternative combination was monoclonal antibody to S-protein and antiserum to C9. Submucosal vessel walls in both normal and diseased colon showed parallel positivity for C3d, C5, C9, terminal complement complex, and S-protein, but the staining intensity and the proportion of positive vessels were significantly higher in inflammatory bowel disease than in controls. In addition, there was significantly more C3c reactivity associated with the terminal complement complex-positive submucosal vessels of active inflammatory bowel disease lesions than in histologically normal colon. Vascular C activation may therefore be a continuous process in active inflammatory bowel disease lesions, presumably related to the degree of inflammation and immune complex formation.

Citations

Jan 1, 1991·Immunologic Research·T S Halstensen, P Brandtzaeg
Jan 1, 1995·Critical Reviews in Clinical Laboratory Sciences·B P Morgan
Apr 1, 1994·European Journal of Clinical Investigation·B P Morgan
Aug 26, 1998·Clinical and Experimental Immunology·L BianconeF Pallone
Apr 13, 2012·American Journal of Physiology. Cell Physiology·Qi CaoAndrew W Stadnyk
Nov 1, 1991·European Journal of Immunology·L I KuppJ G Tew
Apr 25, 2000·The British Journal of Dermatology·Y MatsumaraS Imamura
Aug 1, 1992·Histopathology·A P DhillonR E Pounder
May 17, 2002·The Journal of Pathology·Vera Demarchi AielloJosé A Halperin
May 1, 1993·Archives of Disease in Childhood·T T MacDonald
Jan 24, 2013·Journal of Clinical Biochemistry and Nutrition·Tomoki AomatsuAkira Andoh
May 9, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jennifer Schepp-BerglindStephen Tomlinson
Aug 1, 1994·Annals of Medicine·H Suomalainen, E Isolauri
Dec 1, 1996·Journal of Gastroenterology·R P MacDermott
Oct 9, 2020·Medical Molecular Morphology·Naohiko GunjiHiromasa Ohira
Feb 17, 1998·Biochemical Pharmacology·D F McColeA W Baird
Mar 1, 1996·Baillière's Clinical Gastroenterology·R T Przemioslo, P J Ciclitira
Dec 1, 1995·Gastroenterology·T S GaginellaA Keshavarzian
Mar 1, 1994·Baillière's Clinical Gastroenterology·T T MacDonald, S H Murch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.